Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:64-65 (14 January), doi:10.1136/bmj.332.7533.64
There's still a long way to go to get health technology evidence into practice
| The first 150 words of the full text of this article appear below. |
Throughout the world, healthcare innovations have put pressure on limited resources while governments and patients have demanded top quality, yet cost effective, services. This makes it increasingly difficult for anyone who plans, provides, or receives health services to judge which intervention to usewhat works, how well, at what cost, for whom, in what circumstances, and with what impact? Health technology assessment (HTA) is a multidisciplinary specialty whose purpose is to bring together the evidence to answer those questions.1 It boasts a thriving international scientific society (Health Technology Assessment International; www.htai.org) and a global network of more than 40 public sector agencies (International Network of Agencies for Health Technology Assessment; www.inahta.org). It evaluates the costs, effectiveness, and sometimes the wider impact of any intervention used in the care of patients, including medicines, devices, techniques, and skills. In the UK, for example, the HTA programme (www.ncchta.org) has
John Gabbay, emeritus professor
Wessex Institute for Health Research and Development, University of Southampton, Southampton SO16 7PX
(jg3@soton.ac.uk)
Tom Walley, professor of clinical pharmacology
Departmentt of Pharmacology and Therapeutics, University of Liverpool, Liverpool L69 3GF
Read all Rapid Responses